Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.61222 | 72 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.97455 | 66 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.50611 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.49545 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.57448 | 72 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.5186 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.22 | 68 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.65975 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.11026 | 76 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.62187 | 72 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.34898 | 70 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.45866 | 71 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.4798 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.49862 | 71 |